Nuritas launches PeptiYouth™ – The first ever AI discovered clinically proven anti-aging molecule.
Nuritas, the world leader in Artificial Intelligence-based peptide discovery, launches PeptiYouth™, a peptide discovered within pea and which, following clinical trials, has been shown to significantly reduce cellular aging.
Using their proprietary ground-breaking AI technology NπΦ (pronounced N-pi-fy or Nuritas Peptide Finder), Nuritas discovered and unlocked this peptide from the Pea Proteome. PeptiYouth™ has been clinically tested in a 40-person double blind placebo trial and shown to improve cellular regeneration. After only 28 days of PeptiYouth™ use, human clinical trials showed a significant reduction in wrinkle depth, reduction in skin roughness, reduction in skin inflammation and enhanced collagen production.
The innovative Nuritas research behind PeptiYouth™ is also supported by a peer-reviewed publication “The anti-ageing effects of a natural peptide discovered by Artificial Intelligence” in the International Journal of Cosmetic Science.
“I am unbelievably proud of our team who worked tirelessly to make this happen. We have spent years refining our AI and machine learning platform in combination with our world class in-house laboratory and team of scientific experts. PeptiYouth™ is the first of a suite of clinically tested ingredients Nuritas™ will be launching in the coming months. This marks a step-change in the use of Peptides as active ingredients as well a massive step for the use of AI as a discovery tool augmenting human research capabilities ” commented Dr Nora Khaldi, Nuritas Founder and CEO.
For more information and press pack contact: